4,5-MDO-DMT

4,5-MDO-DMT
Names
	Preferred IUPAC name 2-(2H,6H-[1,3]Dioxolo[4,5-e]indol-8-yl)-N,N-dimethylethan-1-amine
	Other names 4,5-Methylenedioxy-N,N-dimethyltryptamine
Identifiers
CAS Number	81249-30-1 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL28354 ;
ChemSpider	23126498 ;
PubChem CID	44278540;
UNII	L83E2J7P8Z ;
CompTox Dashboard (EPA)	DTXSID201027182 ;
	InChI InChI=1S/C13H16N2O2/c1-15(2)6-5-9-7-14-10-3-4-11-13(12(9)10)17-8-16-11/h3-4,7,14H,5-6,8H2,1-2H3 Key: ZMKRWFZFMOKVCP-UHFFFAOYSA-N;
	SMILES CN(C)CCC1=CNC2=C1C(OCO3)=C3C=C2;
Properties
Chemical formula	C13H16N2O2
Molar mass	232.283 g·mol−1
Melting point	93–95 °C (199–203 °F; 366–368 K)
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

4,5-MDO-DMT, or 4,5-methylenedioxy-N,N-dimethyltryptamine, is a lesser-known psychedelic drug. It is the 4,5-methylenedioxy analog of DMT. 4,5-MDO-DMT was first synthesized by Alexander Shulgin, though in his book TiHKAL it was not tested to determine its psychoactive effects. 4,5-MDO-DMT has been the subject of limited subsequent testing; with behavioral disruption studies performed in male rats indicating that its hallucinogenic potency is less than that of 4,5-MDO-DiPT but greater than that of 5,6-MDO-DiPT.^[1]

References

^ ^a ^b Kline, Toni B.; Benington, Frederick; Morin, Richard D.; Beaton, John M. (August 1982). "Structure-activity relationships in potentially hallucinogenic N,N-dialkyltryptamines substituted in the benzene moiety". Journal of Medicinal Chemistry. 25 (8): 908–913. doi:10.1021/jm00350a005. PMID 7120280.

External links

This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it.

[Kline-1] Kline, Toni B.; Benington, Frederick; Morin, Richard D.; Beaton, John M. (August 1982). "Structure-activity relationships in potentially hallucinogenic N,N-dialkyltryptamines substituted in the benzene moiety". Journal of Medicinal Chemistry. 25 (8): 908–913. doi:10.1021/jm00350a005. PMID 7120280.

[1]